The Cancer Letter
Read our stories on the web, your mobile, or by PDF.

The Oct. 21 issue of The Cancer Letter is available at www.cancerletter.com.


In this issue:
  • Biden Delivers Task Force Report—Five Moonshot Goals in Cancer
  • Obama: The Moonshot, “Architecture and a Framework” for Cancer Research
  • LLS Starts Beat AML Master Trial
  • Fuchs Named Director at Yale; Cox Wins Statistics Top Prize 
  • Lartruvo Gets Accelerated Approval for Sarcoma; Tecentriq Approved for Metastatic NSCLC
  • Califf, Bach, Jasin, Offit, Venter Among New Members of NAM 
Site License Subscribers with IP access, please click http://cancerletter.com/ip-login/.
Individual Subscribers may have to reset their passwords to log into our new membership system. For step-by-step instructions, please consult our LOGIN FAQ if you have trouble logging in or resetting your password. Feel free to call us at 202-362-1809 or reach us at: paul@cancerletter.com (on ext. 2) or matthew@cancerletter.com (ext. 3).

Site license subscribers with IP access include faculty/staff located at: 
  • AbbVie
  • AHC St. Lukes Medical Center
  • American Society of Clinical Oncology
  • AstraZeneca
  • Baptist Health Cancer Research Network
  • Baylor College of Medicine
  • Beth Israel Deaconess Medical Center
  • Cancer Treatment Centers of America
  • Carolinas Healthcare
  • City of Hope
  • Cleveland Clinic Cancer Center
  • Dana Farber Cancer Institute
  • ECOG-ACRIN
  • Eli Lilly & Co.
  • Emory University Winship Cancer Institute
  • Fox Chase Cancer Center
  • Fred Hutchinson Cancer Research Center
  • Genentech
  • Georgetown University Lombardi Cancer Center
  • Georgia Cancer Center at Augusta University
  • H. Lee Moffitt Cancer Center
  • Indiana University Melvin and Bren Simon Cancer Center
  • Inova Health System
  • Johns Hopkins Medicine
  • Loyola Medicine
  • Mallinckrodt
  • The Mayo Clinic
  • Memorial Sloan-Kettering Cancer Center
  • NCCN
  • New York University
  • Northwestern University
  • Norton Healthcare
  • Novartis
  • NSABP
  • The Ohio State University
  • Oregon Health and Science University
  • Penn Medicine
  • Pfizer
  • Roche
  • Roswell Park Cancer Institute
  • Sanofi
  • Sanford-Burnham Medical Research Institute
  • Sidney Kimmel Cancer Center at Thomas Jefferson University
  • Siteman Cancer Center
  • Stanford University
  • St. Jude Children's Research Hospital
  • Swedish Cancer Institute
  • Takeda
  • Temple Cancer Center
  • Tisch Cancer Institute-Icahn School of Medicine at Mount Sinai
  • Universidad de Granada
  • University of Arizona Cancer Center
  • University of California, San Francisco
  • University of California, San Diego
  • University of California, Irvine
  • University of Chicago
  • University of Colorado at Denver
  • University of Illinois Cancer Center
  • University of Florida
  • University of Kentucky Markey Cancer Center
  • University of Kansas
  • University of Maryland Greenebaum Cancer Center
  • University of Miami
  • University of Michigan Cancer Center
  • University of North Carolina, Chapel Hill 
  • University of Pittsburgh Cancer Center
  • University of Southern California
  • University of Texas Southwestern
  • University of Virginia
  • University of Wisconsin
  • US Army Medical Research & Materiel Command, CDMRP
  • Vanderbilt-Ingram Cancer Center
Other site license subscribers or those with group subscriptions should contact their administrator or librarian for access information.
You are receiving this email because you are a subscriber to The Cancer Letter or have opted in to The Cancer Letter news alerts.

Unsubscribe <<Email Address>> from this list | Forward to a friend | Update your profile
Our mailing address is:
The Cancer Letter
PO Box 9905
Washington, DC 20016

Add us to your address book

Copyright (C) 2015 The Cancer Letter All rights reserved.
Email Marketing Powered by Mailchimp